Michael Richards is a Research Assistant Professor in the Department of Surgery, Division of Vascular Surgery at the University of Rochester Medical Center. He received his Ph.D. in Biomedical Engineering from Boston University in 2007. The primary focus of his graduate work was the three-dimensional modeling of the mechanics of soft tissues, specifically breast tissue and breast cancer. This work utilized both ultrasound and X-ray images to measure tissue motion for use in solving the elastic inverse problem.
Following completion of his degree, he was a Post-Doctoral Fellow in the Department of Radiology at the University of Michigan, where he continued his work with breast tissue modeling in addition to beginning his work with cardiovascular mechanics. He then moved to the Parametric Imaging Research Laboratory at the University of Rochester, where he studied the use of IVUS elastography for the diagnosis of vulnerable atherosclerotic plaques.
He is currently a Co-PI in the Cardiovascular Engineering Laboratory (CVEL) at the University of Rochester Medical Center. His work is focused on the optimization of tissue motion or strain estimation algorithms using non-invasive ultrasound imaging as it is applied to problems in cardiovascular mechanics. He is also continuing his work in applying mechanical modeling to study cardiovascular mechanics, both by studying finite element simulations of these problems and by solving the elastic inverse problem. His primary application is the study of abdominal aortic aneurysms (AAA).
Dr. Schwarz is a Professor of Medicine at the University of Rochester Medical Center where he has been the director of the Echocardiography Laboratory since 1992. Dr. Schwarz also holds a position as a Research Professor in Electrical and Biomedical Engineering at the Rochester Institute of Technology.
Dr. Schwarz received his undergraduate degree in 1979 at Bowdoin College in Physics. Dr. Schwarz studied medicine at the University of Rochester, where he completed medical school, residency and cardiology fellowship. During his training years, he developed an interest in studying ways of improving the quality and efficiency of treating cardiovascular disease. Dr. Schwarz then joined the faculty at the University of Rochester Medical Center, where he is now Professor of Medicine.
Dr. Schwarz' primary day to day focus remains improving the care of patients through excellence in cardiac imaging. To this end, he has instituted a program to increase quantification and accuracy of echocardiographic imaging studies. Dr. Schwarz calls this program
Echo 2.0, and it includes quantifying right and left ventricular anatomy and systolic/diastolic function using all available means, and using innovative new measurements to fully characterize valvular anatomy/function and overall cardiovascular physiology. These efforts have already lead to a reduction in the need for invasive procedures and improved patient outcome.
Dr. Schwarz has been the Director of the Echocardiography Lab at the University of Rochester Medical Center since 1992. The Echocardiography Lab is staffed by 14 so-nographers and 7 nurses, and they perform over 14,000 procedures a year at the Medi-cal Center and throughout the western upstate NY region using a mobile echocardio-graphy service. Dr. Schwarz has performed and interpreted over 72,000 echocardio-grams, including 10,000 transesophageal studies. He currently attends on about a quarter of all echocardiograms performed at the University of Rochester. Dr. Schwarz is responsible for training 15 cardiovascular fellows a year in echocardiography.
Doran Mix is currently in his fourth year of medical education at the University of Rochester Medical Center. Before beginning his medical training, Mr. Mix received his Bachelor of Science with honors in Computer Engineering from Rochester Institute of Technology. In 2008 he finished his Post-Baccalaureate Program at Bryn Mawr College.
Prior to beginning his final year of medical school, Mr. Mix took a year out from his education to work in the Cardiovascular Engineering Laboratory under an NIH TL1 grant from the Clinical and Translational Science Institute in Rochester, NY.
From July 2011, to July 2012, Mr. Mix made a huge contribution to the development of the lab and its many projects. Throughout the year, Mr. Mix presented the lab’s work at many highly regarded conferences, including several AHA: Arteriosclerosis, Thrombosis and Vascular Biology Annual Meetings. He was also the recipient of several awards, including the Marvin J. Hoffman Translational Science Award (August 2012), the NIH/NCRR TL1 Training Award (P.I. Ankur Chandra, July 2011-July 2012), and the Society for Vascular Surgery Travel Scholarship (June 2012).
Mr. Mix is the Co-inventor on a provisional patent for fenestrated endograft along with Dr. David Gillespie. Additionally, among the many other achievements he accomplished during his research year, Mr. Mix’s work validated and supported several projects. He also designed the image processing algorithm and laser controller for the study of ultrasound contrast.
Mr. Mix intends to pursue a career in Vascular Surgery and continues to work closely with the lab and its Primary Investigators.
- Pulse Wave Velocity Prediction and Compliance Assessment in Elastic Arterial Segments.Cardiovasc Eng Technol. 6, 49-58. (2015 Mar 01).
- Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction ≥ 40.Cardiol J. 22, 382-90. (2015 Jan 01).
- Evaluation and treatment of pump thrombosis and hemolysis.Ann Cardiothorac Surg. 3, 490-5. (2014 Sep 01).